This article was published on August 4, 2015

The FDA has approved the first drug designed using 3D-printing technology


The FDA has approved the first drug designed using 3D-printing technology

The FDA has just approved the world’s first 3D-printed medication, SPRITAM. The seizure drug is meant to be customized for high dosage treatments, and was developed with Aprecia’s ZipDose technology.

SPRITAM’s 3D-printed designed makes it water soluble with a minimal amount of liquid, which absorbs into the blood stream in less than 10 seconds.“By combining 3DP technology with a highly-prescribed epilepsy treatment, SPRITAM is designed to fill a need for patients who struggle with their current medication experience,” Don Wetherhold, Aprecia’s Chief Executive Officer of Aprecia, said in a press release

The use of 3D-printing for medical purposes is not new, but this is the first time the FDA has approved a drug designed by 3D-printing.

➤ FDA approves the first 3D printed drug product [Aprecia]

Webinar: Unicorn DNA: The Blueprint for Scaling Success

What does it take to build a unicorn? Top executives of unicorn companies reveal the mindset, strategies, and innovative thinking that propelled their companies to the top.

Watch Back Now

Read next: 3D printing: It’s the future of… something… Wait, what is it?

Get the TNW newsletter

Get the most important tech news in your inbox each week.